Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-09

FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Quallent Pharmaceuticals Health LLC)

View source ↗

Summary

FDA approved a supplemental application for sertraline hydrochloride (generic) from Quallent Pharmaceuticals Health LLC under ANDA077397.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sertraline hydrochloride (sertraline hydrochloride)

Snippet

SUPPL AP for SERTRALINE HYDROCHLORIDE (SERTRALINE HYDROCHLORIDE)